Stephanie Manson

Stephanie Manson is a prominent figure in the field of health economics and outcomes research (HEOR). Currently serving as the Senior Director of HEOR Excellence at Novartis, she has been instrumental in advancing patient-centered approaches within the pharmaceutical industry. Based in East Hanover, New Jersey, Manson has a strong academic background, having graduated from the University of Oxford.

Professional Background

• Current Role: Senior Director, HEOR Excellence at Novartis (August 2016 - Present)
  • Focuses on health economics and patient-reported outcomes, enhancing the value of oncology treatments.
• Previous Positions:
  • Value Evidence Leader at Novartis (March 2015 - July 2016), where she contributed to the development of value evidence strategies.
  • Value Evidence Leader at GlaxoSmithKline (2011 - March 2015), focusing on health outcomes and evidence generation.
  • Research Associate at United BioSource (2006 - 2011), involved in various research initiatives related to healthcare outcomes.

Manson is also recognized for her active participation in professional organizations, including serving on the Program Committee for ISPOR, which focuses on health economics and outcomes research.12 Her work emphasizes collaboration with patients and decision-makers to address their needs effectively, reflecting her commitment to challenging conventional practices in healthcare.1

Contributions and Philosophy

Manson advocates for a proactive approach to health access and evidence needs, often questioning not just what can be done but what should be done to improve patient outcomes. Her leadership in HEOR aims to bridge gaps between clinical research and real-world applications, ensuring that patient perspectives are integrated into healthcare decision-making processes.13